查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2034015

全球管瓶和小瓶市場：市場規模、佔有率、成長和行業分析：按材料類型、產品類型、最終用途和區域預測（至 2034 年）

Vials and Ampoules Market Size, Share, Growth, And Industry Analysis, By Material Type, By Product Type, By End-Use, And Regional Forecast To 2034
出版日期: | 出版商: Prismane Consulting | 英文 160 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2025年全球管瓶和藥瓶市場規模為110億美元，預計到2034年將達到193億美元，年複合成長率（CAGR）為6.4%，主要受藥品和注射包裝需求的推動。由於製藥和醫療產業對安全、無菌且高完整性的初級包裝解決方案的需求不斷成長，該市場呈現強勁且持續的成長態勢。管瓶和藥瓶是儲存注射劑、疫苗、生物製藥和敏感製劑的必備容器，在確保產品穩定性和防止污染方面發揮重要作用。包括生物製藥和特種藥物在內的全球製藥業的快速擴張，正在推動對可靠包裝解決方案的需求。此外，醫療保健服務的普及、免疫接種計劃的推進以及給藥系統的改進也進一步促進了市場成長。製造商越來越注重高品質的材料、更高的阻隔性能和精密製造，以滿足嚴格的監管標準並確保產品安全。

需求：依材料類型

玻璃因其優異的耐化學性、惰性和維持產品純度的能力，在管瓶和小瓶包裝市場佔據主導地位，使其成為製藥應用領域的首選材料。硼矽酸玻璃尤其因其高耐熱性和耐久性而被廣泛應用。塑膠材料因其輕盈、抗碎裂和成本優勢，在特定應用領域，特別是低風險或一次性應用領域，正受到越來越多的關注。然而，人們對滲透性和化學相互作用的擔憂限制了其在敏感藥品中的應用。此外，包括先進複合材料和塗層玻璃解決方案在內的其他材料正在湧現，以應對諸如破損和分層等挑戰，這體現了材料技術的不斷創新。

需求：依產品類型分類

由於管瓶廣泛用於注射劑、疫苗和生物製藥的包裝，因此佔據了相當大的市場佔有率。西林瓶用途廣泛，可與自動化灌裝系統相容，並能容納多劑量，因此在製藥生產中備受青睞。安瓿瓶也廣泛應用，尤其是在注射劑的單劑量包裝中，其密封性好，能有效防止污染。在需要精確給藥和長期穩定性的應用中，安瓿瓶的使用尤其突出。為了滿足不斷變化的行業需求，其他產品形式也在湧現，包括先進的給藥系統和專為個人化醫療設計的專用容器。

需求：依最終用途分類

受注射劑、疫苗和生物製藥產量成長的推動，製藥業在管瓶和小瓶包裝市場佔據主導地位。嚴格的監管要求和對無污染包裝的需求進一步推動了該領域的需求。食品飲料產業是一個小眾但成長迅速的應用領域，尤其對需要精確劑量控制和高品質包裝的高階液體產品、香精和添加劑的需求不斷成長。運動營養品市場也不斷擴大應用，特別是小劑量包裝的液體補充劑和能量製劑。個人護理應用，包括精華液和化妝品配方，也推動了市場成長，因為品牌商專注於高階、衛生的包裝解決方案。管瓶和小瓶在其他終端應用領域也持續用於特殊用途。

市場促進因素

推動管瓶和小瓶包裝市場發展的主要因素是全球製藥和生技產業的快速成長。注射劑、疫苗和生物製藥需求的不斷成長，需要高品質的無菌包裝解決方案來確保產品的安全性和有效性，這顯著推動了市場擴張。

市場限制因素

玻璃易碎及其帶來的處理難題是市場發展的主要限制因素之一。雖然玻璃具有優異的保護性和惰性，但其脆性會導致產品損失、安全隱患和運輸成本增加，因此亟需尋找替代材料和改進包裝設計。

本報告對全球管瓶和小瓶市場進行了深入分析，提供了市場動態、行業趨勢、各細分市場的需求預測以及製造商概況等資訊。

目錄

第1章：引言

第2章 市場概況

  • 市場演變
  • 需求概覽
  • 產業結構
  • 戰略問題
  • 終端用戶趨勢
  • 成長預測

第3章：經濟與能源展望

  • 國內生產毛額和人口統計數據
  • 貨幣/財政政策

第4章：終端用戶產業的績效及新冠疫情的影響

  • 機能性食品
  • 運動營養
  • 個人護理

第5章：管瓶與西林瓶簡介及市集概覽

  • 產品描述
  • 等級和特性
  • 原料
  • 製造過程
  • 環境問題
  • 價值鏈
  • 目的

第6章 市場動態與產業趨勢

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務

第7章：全球管瓶和小瓶需求分析：按材料類型、產品類型和最終用途（價值）分類（2018-2034 年）

  • 戰略問題及新冠疫情的影響
  • 需求分析與預測（2018-2034）
    • 要求
    • 需求成長率
    • 促進因素分析
    • 其他功能性成分
  • 全球管瓶和安瓿市場：按材料類型分類
    • 玻璃
    • 塑膠
    • 製藥
    • 個人護理和化妝品
    • 其他
  • 全球管瓶與西林瓶市場：依產品類型分類
    • 管瓶
    • 安瓿
  • 全球管瓶與小瓶市場：依最終用途分類
    • 機能性食品
    • 運動營養
    • 個人護理
    • 其他

第8章 需求分析與市場回顧：按地區/國家分類（價值）（2018-2034 年）

  • 戰略問題及新冠疫情的影響
  • 需求分析與預測（2018-2034）
  • 需求成長率
  • 管瓶和安瓿市場：依材料類型分類
  • 管瓶和安瓿市場：依產品類型分類
  • 管瓶和安瓿瓶市場：依最終用途分類
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 西歐
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙
    • 其他西歐國家
  • 中歐/東歐
    • 俄羅斯
    • 波蘭
    • 土耳其
    • 其他中歐和東歐國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中美洲和南美洲
    • 巴西
    • 阿根廷
    • 其他中南美洲
  • 中東
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東國家
  • 非洲
    • 南非
    • 其他中東和非洲

第9章：定價分析

第10章：關鍵策略問題與機會評估

  • 市場吸引力評估
  • 未來潛力及目標市場研究

第11章 策略建議與提案

第12章：公司分析與市佔率分析

  • 管瓶和安瓿生產商的概況和公司分析
    • 基本資料
    • 總部、主要市場
    • 擁有
    • 企業融資
    • 製造地
    • 全球銷售
    • 員工總數
    • 產品系列/服務/解決方案
    • Prismane Consulting 的關鍵業務策略及概況
    • 最新進展
    • 目標公司

第13章附錄

簡介目錄

The global paper void fill market valued at USD 1.5 billion in 2025 is projected to reach USD 2.9 billion by 2034, growing at a CAGR of 7.8% driven by sustainable protective packaging demand in e-commerce and logistics. The global vials and ampoules market valued at USD 11.0 billion in 2025 is projected to reach USD 19.3 billion by 2034, growing at a CAGR of 6.4% driven by pharmaceutical and injectable drug packaging demand. The global vials and ampoules packaging market is witnessing strong and sustained growth, driven by the increasing demand for safe, sterile, and high-integrity primary packaging solutions across pharmaceutical and healthcare industries. Vials and ampoules are critical for storing injectable drugs, vaccines, biologics, and sensitive formulations, ensuring product stability and protection from contamination. With the rapid expansion of the global pharmaceutical sector, including biologics and specialty drugs, the demand for reliable packaging solutions is intensifying. Additionally, growing healthcare access, vaccination programs, and advancements in drug delivery systems are further contributing to market growth. Manufacturers are increasingly focusing on high-quality materials, improved barrier properties, and precision manufacturing to meet stringent regulatory standards and ensure product safety.

Demand by Material Type

Glass dominates the vials and ampoules packaging market due to its superior chemical resistance, inertness, and ability to maintain product purity, making it the preferred choice for pharmaceutical applications. Borosilicate glass, in particular, is widely used for its high thermal resistance and durability. Plastic materials are gaining traction in specific applications due to their lightweight nature, breakage resistance, and cost advantages, especially in non-critical or single-use applications. However, concerns related to permeability and chemical interaction limit their widespread use in high-sensitivity pharmaceutical products. Other materials, including advanced composites and coated glass solutions, are emerging to address challenges such as breakage and delamination, reflecting ongoing innovation in material technology.

Demand by Product Type

Vials account for a significant share of the market, driven by their widespread use in injectable drug packaging, vaccines, and biologics. Their versatility, compatibility with automated filling systems, and ability to support multi-dose applications make them highly preferred in pharmaceutical manufacturing. Ampoules are also widely used, particularly for single-dose packaging of injectable drugs, offering airtight sealing and high protection against contamination. Their use is prominent in applications requiring precise dosing and long-term stability. Other product formats are emerging to meet evolving industry requirements, including specialized containers designed for advanced drug delivery systems and personalized medicine.

Demand by End-Use

The pharmaceuticals segment dominates the vials and ampoules packaging market, driven by the increasing production of injectable drugs, vaccines, and biologics. Stringent regulatory requirements and the need for contamination-free packaging further support demand in this segment. The food & beverage industry represents a niche but growing application area, particularly for premium liquid products, flavorings, and additives requiring precise dosing and high-quality packaging. Sports nutrition is also witnessing increasing adoption, especially for liquid supplements and energy formulations packaged in small-dose formats. Personal care applications, including serums and cosmetic formulations, are contributing to market growth as brands focus on premium and hygienic packaging solutions. Other end-use sectors continue to adopt vials and ampoules for specialized applications.

Market Driver

A key driver of the vials and ampoules packaging market is the rapid growth of the global pharmaceutical and biotechnology sectors. The increasing demand for injectable therapies, vaccines, and biologics requires high-quality, sterile packaging solutions that ensure product safety and efficacy, significantly driving market expansion.

Market Restraint

One of the primary restraints in the market is the risk of glass breakage and associated handling challenges. While glass offers superior protection and inertness, its fragility can lead to product loss, safety concerns, and increased transportation costs, prompting the need for alternative materials and improved packaging designs.

Demand by Region

North America leads the vials and ampoules packaging market, supported by advanced pharmaceutical manufacturing, strong regulatory frameworks, and high demand for biologics and specialty drugs. Europe follows closely, driven by a well-established healthcare system, increasing focus on quality standards, and strong presence of pharmaceutical companies. Asia-Pacific is expected to witness the fastest growth, fueled by expanding pharmaceutical production, increasing healthcare investments, and rising demand for affordable medicines in countries such as China and India. The region's growing role as a global manufacturing hub further strengthens market prospects.

Key Manufacturers

DWK Life Sciences, Phoneix Glass, Gerresheimer, Schott Pharma, Lutz Packaging, Weigand Glass, SGD Pharma, Verallia, Verescence, SFAM, Stevanto Group, Bormioli Group, Zifgnano Vetro, Vidrala, Stoelzle Glass Group, Ruscam, Borisovskiy Glass Manufacturing Plant, Sibbiopharm, Shandong Pharmaceutical Glass Co., Ltd., Cangzhou Four Star Glass, Tian Youlyy Industrial CO., Ltd, Zhengchuan Pharmaceutical Packaging, Nipro Corporation, Nihon Yamura Glass, Shiotani Glass Co., Ltd, Kapoor Glass, PGP Glass, Borosil Scientific, Hindustan National Glass, Wheaton Brazil Group, Rigolleau S.A., Other Manufacturers

Table of Contents

1. Introduction

  • 1.1. Scope
  • 1.2. Market Coverage
    • 1.2.1. Material Type
    • 1.2.2. Product Type
    • 1.2.3. End-use
    • 1.2.4. Regions
    • 1.2.5. Countries
  • 1.3. Years Considered
    • 1.3.1. Historical - 2018 - 2023
    • 1.3.2. Base - 2024
    • 1.3.3. Forecast Period - 2025 - 2034
  • 1.4. Research Methodology
    • 1.4.1. Approach
    • 1.4.2. Research Methodology
    • 1.4.3. Prismane Consulting Market Models
    • 1.4.4. Assumptions & Limitations
    • 1.4.5. Abbreviations & Definitions
    • 1.4.6. Conversion Factors
    • 1.4.7. Data Sources

2. Market Synopsis

  • 2.1. Market Evolution
  • 2.2. Demand Overview
  • 2.3. Industry Structure
  • 2.4. Strategic Issues
  • 2.5. End-use Trends
  • 2.6. Growth Forecast

3. Economic & Energy Outlook

  • 3.1. GDP and Demographics
  • 3.2. Monetary & Fiscal Policies

4. End-use Sector Performance and COVID-19 Impact

  • 4.1. Functional Foods
  • 4.2. Sports Nutrition
  • 4.3. Personal Care

5. Introduction to Vials and Ampoules and Market Overview

  • 5.1. Product Description
  • 5.2. Grades & Properties
  • 5.3. Raw Material
  • 5.4. Manufacturing Process
  • 5.5. Environmental Issues
  • 5.6. Value Chain
  • 5.7. Applications

6. Market Dynamics and Industry Trends

  • 6.1. Market Dynamics
    • 6.1.1. Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunities
    • 6.1.4. Challenges

7. Global Vials and Ampoules Demand Analysis, By Material Type, By Product Type, and By End-use (Value) (2018-2034)

  • 7.1. Strategic Issues and COVID-19 Impact
  • 7.2. Demand Analysis and Forecast (2018 - 2034)
    • 7.2.1. Demand
    • 7.2.2. Demand Growth Rate (%)
    • 7.2.3. Driving Force Analysis
    • 7.2.4. Other Functional Ingredients
  • 7.3. Global Vials and Ampoules Market, By Material Type
    • 7.3.1. Glass
    • 7.3.2. Plastic
    • 7.3.3. Pharmaceutical
    • 7.3.4. Personal Care & Cosmetics
    • 7.3.5. Others
  • 7.4. Global Vials and Ampoules Market, By Product Type
    • 7.4.1. Vials
    • 7.4.2. Ampoules
  • 7.5. Global Vials and Ampoules Market, By End-use
    • 7.5.1. Functional Foods
    • 7.5.2. Sports Nutrition
    • 7.5.3. Personal Care
    • 7.5.4. Others

8. Demand Analysis and Market Review, By Region, By Country (Value), (2018- 2034)

  • 8.1. Strategic Issues and COVID-19 Impact
  • 8.2. Demand Analysis and Forecast (2018-2034)
  • 8.3. Demand Growth Rate (%)
  • 8.4. Vials and Ampoules Market, By Material Type
  • 8.5. Vials and Ampoules Market, By Product Type
  • 8.6. Vials and Ampoules Market, By End-Use
  • 8.7. North America
    • 8.7.1. USA
    • 8.7.2. Canada
    • 8.7.3. Mexico
  • 8.8. Western Europe
    • 8.8.1. Germany
    • 8.8.2. France
    • 8.8.3. Italy
    • 8.8.4. United Kingdom
    • 8.8.5. Spain
    • 8.8.6. Rest of Western Europe
  • 8.9. Central & Eastern Europe
    • 8.9.1. Russia
    • 8.9.2. Poland
    • 8.9.3. Turkey
    • 8.9.4. Rest of Central & Eastern Europe
  • 8.10. Asia-Pacific
    • 8.10.1. China
    • 8.10.2. Japan
    • 8.10.3. India
    • 8.10.4. South Korea
    • 8.10.5. ASEAN
    • 8.10.6. Rest of Asia-Pacific
  • 8.11. Central & South America
    • 8.11.1. Brazil
    • 8.11.2. Argentina
    • 8.11.3. Rest of Central & South America
  • 8.12. Middle East
    • 8.12.1. Saudi Arabia
    • 8.12.2. UAE
    • 8.12.3. Rest of Middle East
  • 8.13. Africa
    • 8.13.1. South Africa
    • 8.13.2. Rest of MEA

9. Pricing Analysis

10. Key Strategic Issues and Business Opportunity Assessment

  • 10.1. Market Attractiveness Assessment
  • 10.2. Prospective & Target Market Study

11. Strategic Recommendation & Suggestions

12. Company Analysis and Market Share Analysis

  • 12.1. Vials and Ampoules Manufacturers Profiles/ Company Analysis
    • 12.1.1. Basic Details
    • 12.1.2. Headquarter, Key Markets
    • 12.1.3. Ownership
    • 12.1.4. Company Financial
    • 12.1.5. Manufacturing Bases
    • 12.1.6. Global Turnover
    • 12.1.7. Total Employee
    • 12.1.8. Product Portfolio / Services / Solutions
    • 12.1.9. Key Business Strategies adopted and Prismane Consulting Overview
    • 12.1.10. Recent Developments
    • 12.1.11. Companies Covered
      • 12.1.11.1. DWK Life Sciences
      • 12.1.11.2. Phoneix Glass
      • 12.1.11.3. Gerresheimer
      • 12.1.11.4. Schott Pharma
      • 12.1.11.5. Lutz Packaging
      • 12.1.11.6. Weigand Glass
      • 12.1.11.7. SGD Pharma
      • 12.1.11.8. Verallia
      • 12.1.11.9. Verescence
      • 12.1.11.10. SFAM
      • 12.1.11.11. Stevanto Group
      • 12.1.11.12. Bormioli Group
      • 12.1.11.13. Zifgnano Vetro
      • 12.1.11.14. Vidrala
      • 12.1.11.15. Stoelzle Glass Group
      • 12.1.11.16. Ruscam
      • 12.1.11.17. Borisovskiy Glass Manufacturing Plant
      • 12.1.11.18. Sibbiopharm
      • 12.1.11.19. Shandong Pharmaceutical Glass Co., Ltd.
      • 12.1.11.20. Cangzhou Four Star Glass
      • 12.1.11.21. Tian Youlyy Industrial CO., Ltd
      • 12.1.11.22. Zhengchuan Pharmaceutical Packaging
      • 12.1.11.23. Nipro Corporatio
      • 12.1.11.24. Nihon Yamura Glass
      • 12.1.11.25. Shiotani Glass Co., Ltd
      • 12.1.11.26. Kapoor Glass
      • 12.1.11.27. PGP Glass
      • 12.1.11.28. Borosil Scientific
      • 12.1.11.29. Hindustan National Glass
      • 12.1.11.30. Wheaton Brazil Group
      • 12.1.11.31. Rigolleau S.A.
      • 12.1.11.32. Other Manufacturers

13. Appendices

  • 13.1. Demand- Regions
  • 13.2. Demand- Countries